Beranda › Kanker Kandung Kemih › Missouri › St. Louis
Uji klinis Kanker Kandung Kemih di St. Louis, MO
22 studi untuk Kanker Kandung Kemih mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Washington University School of Medicine, St Louis
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Menerima pesertaFase 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- dan 1 lainnya
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Menerima pesertaFase 1
- Washington University School of Medicine in St. Louis, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- dan 4 lainnya
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- Washington University, School of Medicine, St Louis
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Menerima pesertaFase 2
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi jauhnya
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi jauhnya
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- dan 5 lainnya
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- dan 5 lainnya
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- Washington University School of Medicine, St Louis
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Menerima pesertaFase 1
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Menerima pesertaFase 1/2
- Washington University, St Louis
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Menerima pesertaFase 2
- Specialty Clinical Research of St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Menerima pesertaStudi observasional
- Washington University School of Medicine, St Louis
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 3
- Renown Regional Medical Center, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Menerima pesertaFase 1
- Washington University in St. Louis, St Louis
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Menerima pesertaFase 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- dan 4 lainnya
IDOV-Immune for Advanced Solid Tumors
Menerima pesertaFase 1
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Menerima pesertaStudi observasional
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Menerima pesertaStudi observasional
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, St Louis
Uji klinis Kanker Kandung Kemih di kota lain
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Washington, DC26 studi
- Boston, MA26 studi
- Baltimore, MD24 studi
- Los Angeles, CA24 studi
- Seattle, WA21 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Edison, NJ21 studi
Studi lain di St. Louis
- Kanker Paru Non-Sel Kecil73 studi
- Kanker Payudara64 studi
- Kanker Metastatik54 studi
- Kanker Kolorektal50 studi
- Kanker (semua jenis)46 studi
- Kanker Prostat46 studi
- Kanker Paru39 studi
- Kanker Ovarium38 studi
- Kanker Pankreas33 studi
- Kanker Endometrium29 studi
- Karsinoma Sel Skuamosa Kepala dan Leher28 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.